Artemis US Select Fund quarterly review, September 2023
Cormac Weldon and Chris Kent, managers of the Artemis US Select Fund, report on the fund over the quarter to 30 September 2023.
Source for all information: Artemis as at 30 September 2023, unless otherwise stated.
Fund objective
The fund’s objective is to grow capital over a five-year period.
Review of Q3 2023
"Higher for longer"
Investors' focus for much of the quarter was on the prospect of easing inflation and what action the Federal Reserve (Fed) would take on interest rates. As the quarter began, the prevailing sentiment was that a 'soft landing' (a mild economic slowdown) would allow the Fed to start to cut interest rates towards the end of 2023. By the time it drew to a close, however, it had become clear that certain elements of inflation - particularly wage inflation - were proving more persistent than had been hoped. In response, the Fed signalled that rates would need to remain higher for longer, which contributed to the US stockmarket having its worst month of the year during September.
Performance varied across the market, with the sectors that are sensitive to changes in interest rates coming under the greatest pressure. As such, utilities and real estate were the key underperformers. Yet while most sectors ended the quarter lower, energy and communication services rose.
The fund outperformed the market
Over the quarter, the fund returned 2.6% (in sterling terms) while its benchmark the S&P 500 Index1 returned 0.8%. The IA North America NR, the fund’s comparator benchmark2, also returned 0.8%.
For full five-year discrete performance, please see below. Please remember that past performance is not a guide to the future.
Positives
Constellation Energy - This nuclear power/clean energy supplier is one of our biggest holdings. So we were pleased to see it continue to perform well. Good news on profits is being driven by its customers' willingness to pay more given the volatility in energy prices and, perhaps more importantly, by the fact that Constellation is seen as a reliable supplier. Its reliability and focus on clean energy also make it an indirect beneficiary of the AI wave as energy-intensive data centres are being built in the states that Constellation serves.
Meta (formerly Facebook) – Meta announced second-quarter profits that beat expectations. Its recovery story is increasingly well understood by investors. The benefits of last year's cost cutting are clear. The market now appreciates that the slowdown in its revenues was due to its pivot to Reels (a short video format) and a transitory loss of advertising efficacy due to Apple’s privacy changes. We still think the growth potential for Meta from its investment in AI and datacentre infrastructure is underestimated.
Negatives
Dexcom – Dexcom is a pharmaceuticals company that specialises in continuous glucose monitoring systems (CGMs) for diabetes management. Excitement about the potential for novel 'GLP-1' diabetes drugs sent its shares lower. Novo Nordisk and Eli Lilly both have drugs that not only treat Type 2 diabetes but can also be used to treat obesity. The market believed that this would decrease the demand for CGMs and so Dexcom’s share price fell. We take a different view; rather, CGMs have a role to play in helping manage the adoption of these new GLP-1 drugs.
CSX – Shares in rail freight company CSX underperformed over the quarter as weekly shipping volumes failed to show the increase that had been anticipated. In addition, the company announced that its chief operating officer was leaving. This is an important role in this business and the share price was hit on the day of the news. CSX subsequently announced it had hired an experienced replacement to fill the vacancy.
Less-than-truckload holdings receives a boost…
We have held Saia, a 'less-than-truckload' (LTL) freight company, for some time. We recently added more exposure to this subsector with the purchase of TFI International (TFII). For Saia, we have been optimistic for a long time about their ability to work towards being a best-in-class national carrier, which should result in both higher revenue and better profitability. In the case of TFII, we see a major opportunity to improve the profitability of the LTL business it acquired from UPS.
During the third quarter, there was a major change in the less-than-truckload industry. Yellow Corp (formerly a top five carrier by revenue and volume), filed for bankruptcy following years of financial challenges. Yellow's freight is now being shipped by other companies and our holdings have been beneficiaries.
Transactions
We bought Blackstone, a leading alternative asset manager. We believe there are a number of attractive growth drivers for the private asset industry, and Blackstone's brand and investment track record put it in a very good position.
We sold food producer Kraft Heinz as the pricing power it attained during and after Covid appears to be ebbing away.
Outlook
There are risks on the horizon as the market contemplates higher-for-longer interest rates and their likely impact on economic growth. The US stockmarket has performed well over the year to date, but there has been huge dispersion in share price returns beneath the headline return. We believe this will continue to present active managers with an opportunity to find mispriced businesses. For example, we continue to see value in the life sciences area which has struggled this year because of near-term concerns. When companies next report results, we will be looking closely for signs that order trends for our life sciences companies are improving. We will also be hoping for evidence of improved profitability at our trucking companies following the bankruptcy of Yellow Corp.
Discrete performance, 12 months to 30 September |
2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Artemis US Select Fund | 7.6% | -5.1% | 20.0% | 11.6% |
12.3% |
S&P 500 TR GBP | 11.2% | 2.1% | 24.6% | 9.8% | 10.3% |
IA North America NR | 7.6% | -2.1% | 26.7% | 9.0% | 7.2% |
Source: Artemis/Lipper Limited, class I accumulation GBP to 30 September 2023.
All figures show total returns with dividends and/or income reinvested, net of all charges.
Performance does not take account of any costs incurred when investors buy or sell the fund.
Returns may vary as a result of currency fluctuations if the investor's currency is different to that of the class.
Benchmark is S&P 500 TR.
Market volatility risk
The value of the fund and any income from it can fall or rise because of movements in stockmarkets, currencies and interest rates, each of which can move irrationally and be affected unpredictably by diverse factors, including political and economic events.
Currency risk
The fund’s assets may be priced in currencies other than the fund base currency. Changes in currency exchange rates can therefore affect the fund's value.
Concentration risk
The fund may have investments concentrated in a limited number of holdings. This can be more risky than holding a wider range of investments.
THIS IS A MARKETING COMMUNICATION. BEFORE MAKING ANY FINAL INVESTMENT DECISIONS, REFER TO THE FUND PROSPECTUS, AVAILABLE IN ENGLISH, AND KIID/KID, AVAILABLE IN ENGLISH AND IN YOUR LOCAL LANGUAGE DEPENDING ON LOCAL COUNTRY REGISTRATION, FROM WWW.ARTEMISFUNDS.COM OR WWW.FUNDINFO.COM.
ARTEMIS DOES NOT PROVIDE INVESTMENT ADVICE ON THE ADVANTAGES OR SUITABILITY OF ITS PRODUCTS AND NO INFORMATION PROVIDED SHOULD BE VIEWED IN THIS WAY. ARTEMIS ONLY PROVIDES INFORMATION ABOUT ITS OWN PRODUCTS AND SERVICES AND DOES NOT ADVISE INVESTORS. SHOULD YOU BE UNSURE ABOUT THE SUITABILITY OF AN INVESTMENT, YOU SHOULD CONSULT A SUITABLY QUALIFIED PROFESSIONAL ADVISER.